SU5402: Difference between revisions
Jump to navigation
Jump to search
imported>Kevin |
imported>Mfisher |
||
| (One intermediate revision by one other user not shown) | |||
| Line 15: | Line 15: | ||
==References== | ==References== | ||
*[https://pubchem.ncbi.nlm.nih.gov/compound/su5402 | *[https://pubchem.ncbi.nlm.nih.gov/compound/su5402 PubChem CID=5289418] | ||
*[http://www.xenbase.org/literature/article.do?articleId=40921&method=display Atkinson-Leadbeater et al., 2010] | *[http://www.xenbase.org/literature/article.do?articleId=40921&method=display Atkinson-Leadbeater et al., 2010] | ||
*[http://www.xenbase.org/literature/article.do?articleId=39027&method=display 39027] | *[http://www.xenbase.org/literature/article.do?articleId=39027&method=display 39027] | ||
Latest revision as of 11:52, 19 August 2016
Description
"SU-5402 is a FGFR antagonist and angiogenesis inhibitor."
- -Sigma product description
Genes Affected
Suppliers
Usage Notes
References
- PubChem CID=5289418
- Atkinson-Leadbeater et al., 2010
- 39027
- 263
- 6984
- 45656
- Atkinson-Leadbeater et al.,2015
- Chung et al., 2004
>104 Xenbase articles contain a reference to SU5402 according to textpresso